Founding Team Member of MAC Cosmetics, Julie Toskan, Joins MYM International Brands Inc. Board of Directors

VANCOUVER, British Columbia, September 17, 2019 – MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”) is pleased to announce Julie Toskan, founding team member of global cosmetics giant “MAC Cosmetics”, has joined the board of directors at MYM International Brands Inc. (“International Brands”).

Both a business executive and philanthropist, Julie has an impressive track record which includes a proven expertise in helping build a global brand. She was part of the core founding group of MAC Cosmetics, one of the world’s top makeup brands.

Julie is also the founder of the Youth and Philanthropy Initiative (YPI), the largest youth directed participatory grantmaking organization in the world.

“We are extremely honoured to have someone of Julie’s stature join our board of directors,” said Erick Factor, CEO of MYM International Brands. “Her experience as part of the founding team of one of the world’s most accomplished cosmetics companies will prove instrumental in our efforts to successfully create and market CBD consumer products. Her nationally recognized philanthropic work is a testament to her integrity and principles.”

“I’ve always been driven to new ways of thinking, innovation, and social development,” said Julie. “I’m excited to be part of an organization within the CBD consumer products sector made up of such an inspiring team of people. I’m interested in changing people’s perception of what cannabis products mean in today’s society and the potential for helping people understand the health benefits of CBD.”

Julie has received numerous awards, including Canadian Best Practice in Civic Education; Ontario Premier’s Award for Philanthropy in Education; Ontario Medal for Good Citizenship; the Governor General of Canada’s Meritorious Service Award; and an Honorary Doctorate in Civil Law from St. Mary’s University in Halifax, Nova Scotia.

Julie currently resides in Toronto and is CEO of “Genius 100 Foundation”, a networking organizanization that partners people doing social good with those that want to invest in the charitable sector.

About MYM Nutraceuticals Inc.
MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and CBD-rich hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM International Brands Inc. is dedicated to creating and distributing world-class CBD-rich consumer products around the globe. MYM shares trade in Canada, Germany and the United States under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD
Howard Steinberg, CEO
MYM Nutraceuticals Inc.
www.mym.ca

Investor Relations
778-522-2261
[email protected]

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. The Company disclaims and does not undertake any intention or obligation to revise or update such statements, except as required by applicable law. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis dated April 24, 2019 (the “MD&A”) and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Forward-looking statements may include, without limitation, statements relating to, but not limited to, the Company’s ability to  create or successfully market CBD products or the ability to expand cultivation and distribution initiatives for cannabis and hemp globally or the acquisition of complementary businesses and assets in the technology, nutraceuticals and CBD sectors.

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.